Press Release

Jul 18, 2018
Cytox White Paper now available on Assessing Alzheimer’s disease risk using polygenic risk scoring biomarkers

See Cytox's new White Paper on Assessing Alzheimer’s disease risk using polygenic risk scoring biomarkers for an insightful review of Cytox’s groundbreaking approach and platform.

Download here: Cytox White Paper on Assessing Alzheimer’s disease risk using polygenic risk scoring biomarkers